TITLE

Gout

PUB. DATE
January 2001
SOURCE
CMAJ: Canadian Medical Association Journal;1/23/2001, Vol. 164 Issue 2, p239
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents an imaginary dialogue between the disease gout and a person it is infecting. Suggestion that gout protected the person from conditions such as palsy and dropsy; Reluctance of the person to go to a doctor; Promises of the person to live a healthier life in order to prevent gout.
ACCESSION #
4017442

 

Related Articles

  • Re: Hasegawa EM, Fuller R, Chammas MC, de Mello FM, Goldenstein-Schainberg C: Increased prevalence of simple renal cysts in patients with gout. Rheumatol Int, DOI 10.1007/s00296-012-2380-x. Dhakad, Urmila; Singh, Bhupendra; Yadav, Rahul // Rheumatology International;Jan2014, Vol. 34 Issue 1, p131 

    A letter to the editor in response to the article "Goldenstein-Schainberg C: Increased prevalence of simple renal cysts in patients with gout" by E.M. Hasegawa and colleagues is presented.

  • NUTRITION HOTLINE. HAVALA HOBBS, SUZANNE // Vegetarian Journal;2010, Vol. 29 Issue 2, p2 

    The article presents questions and answers about nutritional factors which may help alleviate the symptoms of gout including which foods to avoid and which lifestyle factors play a role in exacerbating the condition.

  • Gout: patient education and nonpharmacological treatments. Finney, Diana // Nursing & Residential Care;Jul2014, Vol. 16 Issue 7, p383 

    No abstract available.

  • Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response. Wen, CC; Yee, SW; Liang, X; Hoffmann, TJ; Kvale, MN; Banda, Y; Jorgenson, E; Schaefer, C; Risch, N; Giacomini, KM // Clinical Pharmacology & Therapeutics;May2015, Vol. 97 Issue 5, p518 

    The first-line treatment of hyperuricemia, which causes gout, is allopurinol. The allopurinol response is highly variable, with many users failing to achieve target serum uric acid (SUA) levels. No genome-wide association study (GWAS) has examined the genetic factors affecting allopurinol...

  • Gout Prevalence High in CKD.  // Renal & Urology News;Dec2011, Vol. 10 Issue 12, p13 

    The article reports on the result of a study presented at Kidney Week 2011 which shows that patients with chronic kidney disease (CKD) demonstrated a high prevalence rate of gout compared with the general population in the U.S.

  • Allopurinol.  // Reactions Weekly;6/21/2008, Issue 1207, p7 

    The article describes the case of elderly Chinese patients who died after developing drug hypersensitivity syndrome in association with allopurinol therapy. They were part of a retrospective review of patients referred to a dermatology unit with allopurinol hypersensitivity syndrome. After...

  • Febuxostat.  // Reactions Weekly;Feb2015, Vol. 1540 Issue 1, p137 

    The article presents a case study of four patients with gout who received febuxostat and developed skin reactions such as diffused rash and vesicular eruption.

  • Gout. Dunkin, Mary Anne // Arthritis Today;Jan/Feb99, Vol. 13 Issue 1, p26 

    Provides information on gout. Cause of gout; Factors that can aggrevate gout; How gout is diagnosed.

  • HMRs and gout. Rigby, Debbie // Australian Journal of Pharmacy;Oct2012, Vol. 93 Issue 1109, p32 

    The article focuses on patient education regarding gout treatment and prevention. It mentions that early treatment of gout can prevent the risk of any chronic or cardiovascular diseases. It adds that individual treatment plan for gout patients should be based on patient preferences and under the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics